Warning: Last items in stock!
Crizonix (Crizotinib 250mg) is a generic kinase inhibitor indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK) or ROS1-positive as detected by an FDA-approved test.
1.Recommended Dose: 250 mg orally twice daily.
2.Moderate Hepatic Impairment: 200 mg orally twice daily.
3.Severe Hepatic Impairment: 250 mg orally once daily.
4.Severe Renal Impairment: 250 mg orally once daily.
Crizonix (Crizotinib 250mg) is a generic oncologic prescription medicine from Beacon, which is one of the biggest pharmaceutical company in Bangladesh.
For more Prescribing information，please check the → “FDA Prescribing Information”.
|Warnings||Don't take the drug without consulting a qualified doctor or physician|
|Suggested use||Follow the doctor's advice|
|Delivery & Returns||7-14 Days|